Anthony Steele Perry, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 2889 W Ashton Blvd Ste 300, Lehi, UT 84043 Phone: 501-500-6640 |
Trevor A Flood, MD Pathology - Anatomic Pathology & Clinical Pathology Medicare: Not Enrolled in Medicare Practice Location: 2889 W Ashton Blvd Ste 300, Lehi, UT 84043 Phone: 501-500-6640 |
Hillel Kahane, M.D. Pathology - Anatomic Pathology Medicare: Medicare Enrolled Practice Location: 2889 W Ashton Blvd Ste 300, Lehi, UT 84043 Phone: 501-500-6640 |
Jared Lon Szymanski, DO Pathology - Cytopathology Medicare: Accepting Medicare Assignments Practice Location: 2889 W Ashton Blvd Ste 300, Lehi, UT 84043 Phone: 501-500-6640 |
News Archive
Winston Laboratories, Inc., a wholly-owned subsidiary of Winston Pharmaceuticals, Inc., a pharmaceutical company focused on developing and commercializing novel pain management therapies, announced that it has submitted a new drug application (NDA) with the U.S. Food and Drug Administration (FDA) for approval to market its civamide (zucapsaicin) 0.075% cream, CIVANEX®, for the treatment of signs and symptoms of osteoarthritis of the knee.
Oxygen Biotherapeutics, Inc., a development stage biomedical company focused on developing oxygen-rich intravenous and topical products, today announced results for the fiscal year (FY) first quarter ended July 31, 2010.
The Multiple Myeloma Research Foundation (MMRF) today announced that two San Diego area biotech firms, Intellikine and Tragara Pharmaceuticals, Inc. will receive funding via its MMRF Biotech Investment Award program. The MMRF Biotech Investment Awards represent a multi-year research grant commitment to fund the early-stage drug development of novel compounds and approaches that show potential in treating multiple myeloma. Based on the companies' achievement of clearly defined milestones, the MMRF will commit a total of $1,000,000 to each company by the end of 2011.
In around 2004, there was a Phillips paper that discussed a new imaging technique called MPI. At that time, I had an eager, promising graduate student named Matt Ferguson who wanted a project, so I asked him to take a look.
In the coming decades, the population of older adults in the United States will reach unprecedented numbers. By the year 2029, more than one in five Americans will be over the age of 65. And most of them will continue driving. To understand their safety and mobility needs, the AAA Foundation for Traffic Safety has launched a five-year, $12 million Longitudinal Research on Aging Drivers (LongROAD) project with Columbia University's Mailman School of Public Health and six other institutions.
› Verified 5 days ago